ALVO Alvotech Earnings and EPS analysis

Relative Growth: Rel. Growth: 22

Relative Strength: Rel. Strength: 10

Relative Valuation: Rel. Valuation: 46

Relative Profitability: Rel. Profitability: 39

EPS in 2026 (TTM): -$0.29

Last Report Period Date: Mar 31, 2026

Currently, ALVO's current EPS stands at -$0.29, according to the most recent financial reports. For the year 2025, ALVO reported a per-share earnings of $0.1, which marks an increase compared to the EPS of -$0.87 recorded in 2024. ALVO recorded an EPS of $0 for the quarterly period ending on Mar 31, 2026.

ALVO earnings history

Historical annual and quarterly earnings per share (EPS) data for Alvotech

EPS (TTM)

-$0.29

EPS Growth YoY (Quarterly)

-100%

EPS (Quarterly)

EPS Growth (Quarterly)

100%

In 2025, Alvotech's EPS was $0.1, an increase of 111.5% from -$0.87 in 2024. For the fiscal quarter that ended on Mar 31, 2026, the per-share earnings was $0, reflecting a 100% decline compared to the same quarter a year earlier. For the twelve months ending March 2026, the EPS is -$0.29. For the year 2024, the yearly earnings per share was -$0.87, marking an increase of 64.2% compared to 2023.

ALVO earnings chart

ALVO EPS growth history

Earnings per share growth rates over time

EPS Growth YoY (Quarterly)

-100%

EPS growth YoY

111.5%

EPS growth 3Y avg

N/A

EPS growth 5Y avg

N/A

Over the past 12 months, Alvotech has recorded an earnings per share growth of -100% (YoY, quarterly).

ALVO Earnings Waterfall

Breakdown of revenue, profit and net income for Alvotech

ALVO Earnings vs Peers

What are the earnings of ALVO compared to its peers

Stock name	Price to Earnings	EPS grwoth 1Y	EPS grwoth 3Y	EPS grwoth 5Y
VIVS VivoSim Labs Inc.	0.56	91.2%	N/A	N/A
ORMP Oramed Pharmaceuticals Inc	1.74	418.8%	N/A	N/A
OMER Omeros Corp	7.14	98.1%	N/A	N/A
OLMA Olema Pharmaceuticals Inc	N/A	15%	N/A	N/A
ORIC Oric Pharmaceuticals Inc	N/A	19.7%	N/A	N/A
ALVO Alvotech	N/A	111.5%	N/A	N/A

All data is based on quarterly TTM periods, unless otherwise specified.